Trending...
- Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
- Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
- Brewtay Coffee Partners with Alex's Lemonade Stand to Fuel Penn Wynne Volunteers
Expert declares mental health and psychiatry are in a tailspin. CCHR warns of psychiatric treatment risks, rising drug deaths, and poor psychiatric hospital outcomes requiring close scrutiny.
LOS ANGELES - PennZone -- Citizens Commission on Human Rights International, a leading mental health industry watchdog, is calling for a federal audit of the $280 billion spent annually on mental health services, citing decades of failed outcomes and lack of meaningful improvements. Additionally, as CCHR has been exposing since the 1990s, millions of dollars have been wasted on National Institute of Mental Health (NIMH)-funded behavioral and psychiatric research that has included studying whiptail lizards, insects, electric fish and $3.1 million spent on the "vocal learning" of birds. Despite this massive investment, mental health in the U.S. continues to decline. CCHR warns that billions are being squandered on treatment-caused harm, overlooked polypharmacy risks, and rising deaths linked to psychotropic drugs.
President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."
According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles…. But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]
More on The PennZone
Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]
Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]
In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.
There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]
More on The PennZone
Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]
Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]
Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]
Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.
Sources:
[1] time.com/6308096/therapy-mental-health-worse-us/
[2] time.com/6280929/polypharmacy-dangers-essay/
[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/
[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html
[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/
[6] link.springer.com/article/10.1007/s00127-014-0912-2
[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research
[8] peele.net/lib/americanpsychiatry.html
President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."
According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles…. But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]
More on The PennZone
- American Properties Celebrates Grand Opening and Ribbon Cutting Ceremony at Heritage at South
- MoMojo Records signs Arlen Roth; "Blues Grass" slated for August 7, 2026 release
- Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia
- Autism Podcast Helps Parents Understand Why Behavior Is Communication, Not Defiance
- Filmmaker Preston A. Dent to Premiere "Harrisburg-The Movie" at Whitaker Center for the Arts
Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]
Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]
In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.
There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]
More on The PennZone
- Pollock Begg Family Law Attorneys Earn 2026 Pennsylvania Super Lawyers Honors at Every Level
- Research reveals "The Borderless Pay Standard," a 48-point gap between multinational employers and workers on transparent pay expectations
- Global.ai Appoints Freedomtech Solutions as Specialist Partner for Agentic AI
- Communities In Schools of Eastern Pennsylvania's Ready, Set, Graduate! Celebrates Over 100 Students in Two Ceremonies
- Lansdowne Photographer Steven Weisz Selected for Philadelphia City Hall Exhibition
Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]
Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]
Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]
Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.
Sources:
[1] time.com/6308096/therapy-mental-health-worse-us/
[2] time.com/6280929/polypharmacy-dangers-essay/
[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/
[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html
[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/
[6] link.springer.com/article/10.1007/s00127-014-0912-2
[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research
[8] peele.net/lib/americanpsychiatry.html
Source: Citizens Commission on Human Rights
Filed Under: Health
0 Comments
Latest on The PennZone
- JFAB Consulting Elevates Brand with New Identity and Digital Experience
- SteelTree Announces Launch of Its Operational Decision Intelligence Service
- Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
- AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
- AI Predicts the Most Likely 2026 FIFA World Cup Winner
- The AI Production Shift: Why Game Development Is Entering Its Most Accelerated Phase
- World-First AI Humanoid Robot Debuts on Cherie Barber's Ground-breaking Australian Reno Show
- New Survey Reveals America's Most Feared Bridges for Cyclists — Golden Gate Tops the List
- Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
- NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
- AiBT Advisory Launches AI Deployment Firm for the Mid-Market Companies Big AI Left Behind
- AI Is Closing the Gap Between Offshore Virtual Assistants and Onshore Staff
- CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
- Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
- NewReputation's AI Sentiment Analysis Tool Reaches 2,500 Users as Businesses Demand Clearer Brand Intelligence
- CAPO Supply Announces Opening of Second Location in New Castle, Pennsylvania
- $224 Billion Growing Market in Life Settlements Presents Major Opportunity for New Policy Acquisition Business Plan: DLT Resolution Stock Symbol: DLTI
- Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
- YieldOMega Launches $DOUB Airdrop Campaign Ahead of TimeCurve Launch
- Kaltra Expands Microchannel Water Coil Line for U.S. HVAC Market With New Corrosion-Resistant Tube Technology
